SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: manfredhasler who wrote (14723)9/18/2000 11:06:00 AM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Manfred, since most Biotechs are all about speculation, what do you think the market cap of Xoma will be IF approval of anti-cd11a???? BTW, I agree with you on Xoma should of demanded to do Phase III Neuprex in best possible manner. If the FDA set up unreasonable parameters on a take it or leave it situation, I would of walked. I would also like to think the stockholders would of understood such a situation.